Nepal received 1 million doses of Covishield vaccine bought from India’s Serum Institute

(G.N.S) Dt. 22


Oxford-AstraZeneca’s Covishield is being manufactured by Pune-based Serum Institute of India (SII) which has collaborated with Oxford University and pharmaceutical company AstraZeneca for making the vaccine.

In a fight against Pandemic Covid-19, Nepal has received the one million doses of Covishield vaccine it bought from India’s Serum Institute.

An Air India aircraft carrying the consignment of Covid-19 vaccines landed at the Tribhuvan International Airport in the morning, according to sources at the Indian Embassy.
The Nepal government has decided to procure a total of two million doses of the vaccine manufactured by the SII.

Related posts

Tokyo Olympics updates: Shuttler PV Sindhu lost in straight games 18-21, 12-21 against Tai Tzu-Ying


Germany to lift entry ban, eases travel restrictions on travellers from India and other nations


Start restoration of Hindu temple in Karak within two weeks: Pakistan SC


Leave a Comment